These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11021157)

  • 41. The MMPI-2 Symptom Validity Scale (FBS) not influenced by medical impairment: a large sleep center investigation.
    Greiffenstein MF
    Assessment; 2010 Jun; 17(2):269-77. PubMed ID: 20124428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examination of the MMPI-3 over-reporting scales in a forensic disability sample.
    Tylicki JL; Gervais RO; Ben-Porath YS
    Clin Neuropsychol; 2022 Oct; 36(7):1878-1901. PubMed ID: 33319631
    [No Abstract]   [Full Text] [Related]  

  • 43. Validity of the Miller forensic assessment of symptoms test in psychiatric inpatients.
    Veazey CH; Wagner AL; Hays JR; Miller HA
    Psychol Rep; 2005 Jun; 96(3 Pt 1):771-4. PubMed ID: 16050637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incremental validity of the MMPI-2-RF over-reporting scales and RBS in assessing the veracity of memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Sellbom M
    Arch Clin Neuropsychol; 2010 Jun; 25(4):274-84. PubMed ID: 20335183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of feigned posttraumatic stress disorder: A meta-analysis of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2).
    Nijdam-Jones A; Chen Y; Rosenfeld B
    Psychol Trauma; 2020 Oct; 12(7):790-798. PubMed ID: 32463283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the Minnesota multiphasic personality inventory (MMPI) to identify malingering mental retardation.
    Keyes DW
    Ment Retard; 2004 Apr; 42(2):151-3. PubMed ID: 15008639
    [No Abstract]   [Full Text] [Related]  

  • 47. Utility of the response bias scale (RBS) and other MMPI-2 validity scales in predicting TOMM performance.
    Whitney KA; Davis JJ; Shepard PH; Herman SM
    Arch Clin Neuropsychol; 2008; 23(7-8):777-86. PubMed ID: 18930375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mental disorders--malingering].
    Bonshtein U
    Harefuah; 2008 Jan; 147(1):43-8, 94. PubMed ID: 18300623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A New Index for the MMPI-2 Test for Detecting Dissimulation in Forensic Evaluations: A Pilot Study.
    Martino V; Grattagliano I; Bosco A; Massaro Y; Lisi A; Campobasso F; Marchitelli MA; Catanesi R
    J Forensic Sci; 2016 Jan; 61(1):249-53. PubMed ID: 26305512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparability of the MMPI-2 F(p) and F scales and the SIRS in clinical use with suspected malingerers.
    McCusker PJ; Moran MJ; Serfass L; Peterson KH
    Int J Offender Ther Comp Criminol; 2003 Oct; 47(5):585-96. PubMed ID: 14526598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Raising doubts about claims of malingering: implications of relationships between MCMI-II and MMPI-2 performances.
    Grillo J; Brown RS; Hilsabeck R; Price JR; Lees-Haley PR
    J Clin Psychol; 1994 Jul; 50(4):651-5. PubMed ID: 7983217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of malingering: psychometric evaluation of the Chinese version of the structured interview of reported symptoms-2.
    Liu C; Liu Z; Chiu HF; Carl TW; Zhang H; Wang P; Wu G; Mwansisya TE; Cao L; Hu A; Wang Y; Xue Z
    BMC Psychiatry; 2013 Oct; 13():254. PubMed ID: 24106829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of complex dissociative disorder patients and simulated dissociation in forensic contexts.
    Brand BL; Webermann AR; Frankel AS
    Int J Law Psychiatry; 2016; 49(Pt B):197-204. PubMed ID: 28029435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
    Jones A; Ingram MV
    Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of the new MMPI-2 Malingered Depression scale to individuals undergoing neuropsychological evaluation: relative lack of relationship to secondary gain and failure on validity indices.
    Sweet JJ; Malina A; Ecklund-Johnson E
    Clin Neuropsychol; 2006 Sep; 20(3):541-51. PubMed ID: 16895865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of diagnostic measures based on latent class analysis: a step forward in response bias research.
    Thomas ML; Lanyon RI; Millsap RE
    Psychol Assess; 2009 Jun; 21(2):227-30. PubMed ID: 19485677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samples.
    Wygant DB; Ben-Porath YS; Arbisi PA; Berry DT; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2009 Nov; 24(7):671-80. PubMed ID: 19797242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlates of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) Personality Psychopathology Five (PSY-5) scales in a forensic assessment setting.
    Petroskey LJ; Ben-Porath YS; Stafford KP
    Assessment; 2003 Dec; 10(4):393-9. PubMed ID: 14682485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Refinement of the MMPI-2 F(p) scale is not necessary: a response to Gass and Luis.
    Arbisi PA; Ben-Porath YS; McNulty J
    Assessment; 2003 Jun; 10(2):123-8. PubMed ID: 12801183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.